Thomas T. Thomas, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 2,763 shares at $16.50 ($45K) on 2018-05-17, disclosed to the SEC on 2018-05-18.
Open-market sale of $45k OPNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.17 | 263 | $4K | 9.4% |
| 2 | $16.41 | 500 | $8K | 18.1% |
| 3 | $16.40 | 500 | $8K | 18.1% |
| 4 | $16.50 | 500 | $8K | 18.2% |
| 5 | $16.51 | 500 | $8K | 18.2% |
| 6 | $16.50 | 500 |
| $8K |
| 18.2% |
| Total | $16.44 avg | 2,763 | $45K | 100% |
| Filing → |
| OPNT | SELL | 2021-09-09 | $15K | — | Filing → |
| OPNT | SELL | 2021-08-20 | $16K | — | Filing → |
| OPNT | BUY | 2020-09-08 | $25K | — | Filing → |